Skip to main content

Advertisement

Log in

Factors Responsible for Discordant Response to Neoadjuvant Systemic Therapy in T4b Breast Cancer

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Neoadjuvant systemic therapy is the standard of care in the treatment of locally advanced breast cancer. Heterogeneity of tumour microenvironment complicates the response to the treatment. Very few studies focus on the response pattern of neoadjuvant chemotherapy in locally advanced breast carcinoma. We aim to hypothesize that breast cancer microenvironment has a heterogeneous pattern. This is prominent when skin is involved and can be attributed to a higher distribution of cancer stem cells on the surface compared to the core and is independent of tumour biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Liu SV, Melstrom L, Yao K, Russell CA, Sener SF (2010) Neoadjuvant therapy for breast cancer. J Surg Oncol 101:283–91

    Article  CAS  PubMed  Google Scholar 

  2. Laboratory of drug targets histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių Av. 13, LT-50161, Kaunas, Lithuania Life Sciences Center, Vilnius University, Saulėtekio Av. 7, LT-10257, Vilnius, Lithuania

  3. Ellis IO et al (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479–489

    Article  CAS  PubMed  Google Scholar 

  4. Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P et al (2014) Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/b-catenin negative feedback loop. Stem Cell Res Ther 5:116

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hossain DMS, Panda AK, Manna A, Mohanty S, Bhattacharjee P, Bhatta-charyya S et al (2013) FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity 39:1057–1069

    Article  CAS  PubMed  Google Scholar 

  6. Discordant chemosensitivity pattern in T4b lesions is related to morphologic heterogenity and distribution of cancer stem cells in tumor microenvironment Diptendra K Sarkar, A K Manna, A K Singhal; EJSO Volume 47, Issue 05

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. K. Singhal.

Ethics declarations

Ethics Approval

This study was approved by the ethical committee of our hospital.

Patient Consent

Patients’ informed consents were obtained.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singhal, A.K., Sarkar, D.K., Manna, A.K. et al. Factors Responsible for Discordant Response to Neoadjuvant Systemic Therapy in T4b Breast Cancer. Indian J Surg 84 (Suppl 3), 703–707 (2022). https://doi.org/10.1007/s12262-021-03084-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-021-03084-7

Keywords

Navigation